Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial
Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page
- Check5 days agoChange DetectedRevision/version shown on the page was updated from v3.5.3 to v3.5.4, indicating a new release of the document or tool. This change updates the metadata without altering visible content or functionality.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s software/display revision was updated from v3.5.2 to v3.5.3, indicating a minor update to the site version without changing the underlying study details.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No user-visible content or functionality changes are introduced.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No changes to study data, eligibility criteria, or results.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.3 was added to the page. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.